New trends in the treatment of Diabetes
dc.contributor.advisor | Pórszász, Róbert | |
dc.contributor.advisordept | Department Of Pharmacology And Pharmacotherapy | hu_HU |
dc.contributor.author | Afful, Ewurakua Kotaaba | |
dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
dc.contributor.opponent | Szentmiklósi, József András | |
dc.contributor.opponent | Drimba, László | |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.contributor.opponentdept | Kenézy Kórház Aneszteziológiai és Intenziv Therápiás Osztály | hu_HU |
dc.date.accessioned | 2017-08-23T09:34:20Z | |
dc.date.available | 2017-08-23T09:34:20Z | |
dc.date.created | 2017-05-30 | |
dc.description.abstract | Greater than 360 million persons will develop diabetes by the year 2030. New Insulins analogues, adjunctive non-insulin therapies such as use of incretin agents and SGLT-2 inhibitors are being actively pursued as a novel approach in diabetes therapy. Pluripotent stem cells in the production of pancreatic progenitor or insulin producing cells in also being researched towards the treatment of type 1 diabetes. Information technology has also enabled care providers enhance care process, and provide aid to diabetics . | hu_HU |
dc.description.course | általános orvos | hu_HU |
dc.description.courselang | angol | hu_HU |
dc.description.degree | egységes, osztatlan | hu_HU |
dc.format.extent | 30 | hu_HU |
dc.identifier.uri | http://hdl.handle.net/2437/243131 | |
dc.language.iso | en | hu_HU |
dc.subject | trends | hu_HU |
dc.subject | Diabetes | hu_HU |
dc.subject | Treatment | hu_HU |
dc.subject | New trends | hu_HU |
dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
dc.title | New trends in the treatment of Diabetes | hu_HU |